Polymicrobial Q Fever and Enterococcal Aortic Prosthetic Valve Endocarditis with Aortic Root Abscess

2015 ◽  
Vol 15 (5) ◽  
pp. 326-328 ◽  
Author(s):  
Dafna Yahav ◽  
Israel Kuznitz ◽  
Sharon Reisfeld ◽  
Noa Eliakim-Raz ◽  
Jihad Bishara
Keyword(s):  
Aortic Root ◽  
Prosthetic Valve ◽  
Q Fever ◽  
Prosthetic Valve Endocarditis ◽  
Aortic Root Abscess

scholarly journals A Rare Case of Vagococcus fluvialis Prosthetic Valve Endocarditis and Aortic Root Abscess

2021 ◽  
Vol 8 (1) ◽  
Author(s):  
Back Liam M ◽  
Magdy Joseph ◽  
Guiney Liam ◽  
Luo Roger ◽  
Hussein Akram ◽  
...  
Keyword(s):  
Aortic Root ◽  
Rare Case ◽  
Prosthetic Valve ◽  
Prosthetic Valve Endocarditis ◽  
Aortic Root Abscess

Initial experience with xenograft bioconduit for the treatment of complex prosthetic valve endocarditis

Perfusion ◽  
2017 ◽  
Vol 32 (5) ◽  
pp. 383-388 ◽  
Author(s):  
Apostolos Roubelakis ◽  
Dimos Karangelis ◽  
Syed Sadeque ◽  
Bobby Yanagawa ◽  
Amit Modi ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Root ◽  
Prosthetic Valve ◽  
High Risk Patient ◽  
Recurrent Infection ◽  
Length Of Hospital Stay ◽  
Prosthetic Valve Endocarditis ◽  
Biological Tissues ◽  
Aortic Root Abscess ◽  
The Mean

Introduction: The treatment of complex prosthetic valve endocarditis (PVE) with aortic root abscess remains a surgical challenge. Several studies support the use of biological tissues to minimize the risk of recurrent infection. We present our initial surgical experience with the use of an aortic xenograft conduit for aortic valve and root replacement. Methods: Between October 2013 and August 2015, 15 xenograft bioconduits were implanted for complex PVE with abscess (13.3% female). In 6 patients, concomitant procedures were performed: coronary bypass (n=1), mitral valve replacement (n=5) and tricuspid annuloplasty (n=1). The mean age at operation was 60.3±15.5 years. The mean Logistic European system for cardiac operating risk evaluation (EuroSCORE) was 46.6±23.6. The median follow-up time was 607±328 days (range: 172-1074 days). Results: There were two in-hospital deaths (14.3% mortality), two strokes (14.3%) and seven patients required permanent pacemaker insertion for conduction abnormalities (46.7%). The mean length of hospital stay was 26 days. At pre-discharge echocardiography, the conduit mean gradient was 9.3±3.3mmHg and there was either none (n=6), trace (n=6) or mild aortic insufficiency (n=1). There was no incidence of mid-term death, prosthesis-related complications or recurrent endocarditis. Conclusions: Xenograft bioconduits may be safe and effective for aortic valve and root replacement for complex PVE with aortic root abscess. Although excess early mortality reflects the complexity of the patient population, there was good valve hemodynamics, with no incidence of recurrent endocarditis or prosthesis failure in the mid-term. Our data support the continued use and evaluation of this biological prosthesis in this high-risk patient cohort.

Prosthetic valve endocarditis with extensive aortic root abscess

2003 ◽  
Vol 51 (12) ◽  
pp. 681-684 ◽  
Author(s):  
Keiichi Fujiwara ◽  
Hiroki Hayashi ◽  
Shuji Yamamoto ◽  
Hiroyoshi Komai ◽  
Yoshitaka Okamura
Keyword(s):  
Aortic Root ◽  
Prosthetic Valve ◽  
Prosthetic Valve Endocarditis ◽  
Aortic Root Abscess

scholarly journals AORTIC ROOT ABSCESS: A RARE COMPLICATION OF STAPHYLOCOCCUS EPIDERMIDIS PROSTHETIC VALVE ENDOCARDITIS

CHEST Journal ◽  
2021 ◽  
Vol 160 (4) ◽  
pp. A295
Author(s):  
Sanu Rajendraprasad ◽  
Dorothy Kenny ◽  
Rosa Cruz Torres ◽  
Manasa Velagapudi
Keyword(s):  
Aortic Root ◽  
Staphylococcus Epidermidis ◽  
Prosthetic Valve ◽  
Rare Complication ◽  
Prosthetic Valve Endocarditis ◽  
Aortic Root Abscess

scholarly journals Prosthetic Valve Endocarditis with aortic root abscess

2013 ◽  
Vol 9 (1) ◽  
Author(s):  
Kanne Padmaja ◽  
Vemu Lakshmi ◽  
Mallempati Amaresh ◽  
Ramesh Mishra ◽  
Rosy Chikkala ◽  
...  
Keyword(s):  
Aortic Root ◽  
Prosthetic Valve ◽  
Prosthetic Valve Endocarditis ◽  
Aortic Root Abscess

scholarly journals Relapse of enterococcal prosthetic valve endocarditis with aortic rootabscess following treatment with daptomycin in a patient not fit for surgery

2010 ◽  
Vol 59 (4) ◽  
pp. 482-485 ◽  
Author(s):  
D. A. Enoch ◽  
N. Phillimore ◽  
J. A. Karas ◽  
L. Horswill ◽  
D. A. Mlangeni
Keyword(s):  
Elderly Patient ◽  
Aortic Root ◽  
Prosthetic Valve ◽  
Prosthetic Valve Endocarditis ◽  
Gram Positive ◽  
Aortic Root Abscess

Daptomycin is a novel lipopeptide with activity against Gram-positive organismsincluding enterococci. It is licensed for the treatment of Staphylococcusaureus bacteraemia and right-sided endocarditis, but not endocarditisdue to Enterococcus spp. We report a case of enterococcal prostheticvalve endocarditis with an aortic root abscess in an elderly patient who wasnot fit for surgery. The patient's endocarditis relapsed 9 weeks aftera 6 week course of daptomycin.

scholarly journals Chronic Q fever prosthetic valve endocarditis — an important cause of prosthetic valve dysfunction in Australia

2015 ◽  
Vol 202 (4) ◽  
pp. 212-213 ◽  
Author(s):  
Mohammad Paymard ◽  
Lisa Nicotra ◽  
Andrew Dettrick ◽  
Brendan Bell ◽  
Alex Chaudhuri ◽  
...  
Keyword(s):  
Prosthetic Valve ◽  
Q Fever ◽  
Prosthetic Valve Endocarditis ◽  
Valve Dysfunction ◽  
Prosthetic Valve Dysfunction ◽  
Chronic Q Fever
Sign in / Sign up

Export Citation Format

Share Document